Jb Ias Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 185.85%
- Ebitda 894.86%
- Net Worth 350.72%
- Total Assets 957.37%
About Jb Ias Life Science
Jb Ias Life Science Private Limited (JILSPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 April 2017 (Seven years and ten months 23 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Jb Ias Habiliment Private Limited. The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ishrat Afshan and Zoha Bhabay serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33100MH2017PTC293356
- Company No.
293356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jb Ias Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zoha Bhabay  | Director | 19-Mar-2021 | Current |
| Ishrat Afshan | Director | 19-Mar-2021 | Current |
Financial Performance of Jb Ias Life Science.
Jb Ias Life Science Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 185.85% increase in profit. The company's net worth Soared by an impressive increase of 350.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jb Ias Life Science?
In 2019, Jb Ias Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Growcare Health Solutions Private LimitedIshrat Afshan is a mutual person
Azriel Hospital FoundationZoha Bhabay is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jb Ias Life Science?
Unlock and access historical data on people associated with Jb Ias Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jb Ias Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jb Ias Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
